Stanford, CA, United States of America

Sue Klapholz

This inventor holds 11 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Abgenix, Inc., Cell Genesys, Inc., Amgen Fremont Inc.. Active years: 1994-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sue Klapholz. Retrieved from https://idiyas.com/inventor/sue-klapholz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 81.8


 

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 2,970(Granted Patents)


Company Filing History:


Years Active: 1994-2021

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Sue Klapholz

Introduction: Sue Klapholz is a pioneering inventor based in Stanford, CA, known for her groundbreaking contributions to the field of technology and healthcare.

Latest Patents: Sue Klapholz holds several patents related to medical devices and digital health solutions, showcasing her commitment to improving patient care and outcomes.

Career Highlights: With a background in biomedical engineering, Sue Klapholz has led research teams at renowned institutions, focusing on developing innovative technologies that bridge the gap between healthcare and cutting-edge advancements.

Collaborations: Throughout her career, Sue Klapholz has collaborated with leading experts in the fields of medicine, engineering, and data science, fostering a multidisciplinary approach to problem-solving and innovation.

Conclusion: Sue Klapholz's dedication to pushing the boundaries of technology and healthcare has solidified her reputation as a visionary inventor, shaping the future of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…